what is the imf's istopmm study? early screening for myeloma: advantages, impact, and benefits
Published 8 months ago • 510 plays • Length 3:55Download video MP4
Download video MP3
Similar videos
-
5:00
the international myeloma foundation's (imf) impact in 2022 and the future of the imf
-
1:00:07
istopmm study: the first large-scale myeloma screening study | 2023 imf patient and family seminar
-
2:56
what are early insights from istopmm regarding preventing myeloma progression?
-
8:02
screening for monoclonal gammopathy of undetermined significance: first results from istopmm study
-
3:12
the imf's istopmm (iceland screens treats or prevents multiple myeloma) publishes its first paper.
-
1:05
istopmm: benefits and harms of screening for myeloma precursor disease
-
1:53
istopmm study and early mgus and smm screening | joshua richter, md | ash 2021
-
2:59
what is multiple myeloma?
-
3:14
what are the frontline myeloma treatment options?
-
9:36
screening for myeloma precursors: istopmm, promise, and the questions they have raised
-
8:07
mgus with multiple paraproteins: results from the population-based istopmm screening study
-
6:54
prevalence of smoldering multiple myeloma: results from the istopmm study
-
6:00
istopmm - one year update
-
3:28
what is the black swan research initiative's immune system study on early myeloma development?
-
3:08
what is the imwg and what is its purpose in the field of myeloma research?
-
3:43
what treatment is recommended for a newly diagnosed patient?
-
5:55
mgus and risk of chronic kidney disease: results of the population-based istopmm study
-
8:14
autoimmune diseases are not associated with mgus: results of the population-based istopmm
-
5:10
2023 innovation and impact report | international myeloma foundation reports on key wins in myeloma